Bharat Biotech’s Covaxin allowed to drop ‘clinical trial mode’ label
Bharat Biotech’s Covid-19 vaccine, Covaxin, has been granted restricted emergency use authorisation and will no longer have to carry the “clinical trial mode” label. Serum Institute of India’s Covishield already has this status.
Read Full Story>>